HOW SHOULD WE SUPPORT PATIENTS WITH PRIMARY BRAIN TUMOURS WHO ELECT TO TAKE CANNABINOIDS?

INTRODUCTION: Primary brain tumours account for 3% of new cancer cases (2015) but account disproportionately in terms of mortality and morbidity. With radical treatment prognosis is variable; ranging from 80% survival for 5 years or more for benign meningiomas to a dismal 5% for Glioblastoma multifo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: La, Jessica, Hurwitz, Victoria, Mullens, Laura, Brazil, Lucy, Gullan, Richard, Bhangoo, Ranj, Vergani, Francesco, Beaney, Ronald, Ashkan, Keyoumars, Rooprai, Bali, Swampillai, Angela
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168826/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy129.028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars